| DAY 1 - Friday, 21 October 2022 | ||
| MAIN HALL 08.40 - 09.00 |
Welcome and Introduction to EndoBridge 2022 | |
| MAIN HALL | ||
| 09.00 - 09.30 | Cyclic Cushing's syndrome: Challenges and solutions - Martin Reincke | |
| 09.30 - 10.00 | The changing spectrum of hypophysitis: From lab to clinical practice - Sabrina Chiloiro | |
| 10.00 - 10.30 | Upcoming new treatments for acromegaly - AJ Van Der Lely | |
| 10.30 - 11.00 | Don’t forget the posterior pituitary: new developments in diabetes insipidus - Mirjam Christ-Crain | |
| 11.00 - 11.20 | Coffee Break | |
| 11.20 - 12.50 | Interactive Case Discussion Sessions | |
| HALL A | Pituitary |  |
| HALL B | Adrenal | |
| HALL C | Neuroendocrine tumors | |
| HALL D | Obesity, metabolism and nutrition | |
| 12.50 - 14.00 | Lunch | |
| 14.00 - 15.30 | Interactive Case Discussion Sessions | |
| HALL A | Pituitary | |
| HALL B | Adrenal | |
| HALL C | Neuroendocrine tumors | |
| HALL D | Obesity, metabolism and nutrition | |
| 15.30 - 15.50 | Coffee Break | |
| MAIN HALL | ||
| 15.50 - 16.20 | Diagnostics of underlying causes of obesity - Liesbeth van Rossum | |
| 16.20 - 16.50 | The new avenues of the pharmacotherapy for obesity - Uberto Pagotto | |
| 16.50 - 17.20 | Recent developments in the pharmacologic management of hypercholesterolemia - David Saxon | |
| 17.20 - 17.50 | NAFLD/NASH in the continuum of cardiometabolic risk: Implications for diagnosis & management - Christos S. Mantzoros | |
| DAY 2 - Saturday, 22 October 2022 | ||
| MAIN HALL | ||
| 09.00 - 09.30 | Comprehensive management of diabetes and new strategies in the post - CVOT era - Jane Reusch | |
| 09.30 - 10.00 | Youth-onset type 2 diabetes: How does it differ from the adult-onset form? - Kristen Nadeau | |
| 10.00 - 10.30 | An insider's look into the ADA standards of care in diabetes - Robert Gabbay | |
| 10.30 - 11.00 | Approach to diabetic kidney disease and hypertension - Anthony Heagerty | |
| 11.00 - 11.20 | Coffee Break | |
| 11.20 - 12.50 | Interactive Case Discussion Sessions | |
| HALL A | Diabetes | |
| HALL B | Thyroid | |
| HALL C | Bone and calcium | |
| HALL D | Male reproductive endocrinology | |
| 12.50 - 14.00 | Lunch | |
| 14.00 - 15.30 | Interactive Case Discussion Sessions | |
| HALL A | Diabetes | |
| HALL B | Thyroid | |
| HALL C | Bone and calcium | |
| HALL D | Female reproductive endocrinology | |
| 15.30 - 15.50 | Coffee Break | |
| MAIN HALL | ||
| 15.50 - 16.20 | Year in thyroidology - Clinical Update - Angela Leung |  |
| 16.20 - 16.50 | Precision thyroid care: Avoiding over-and under treatment of thyroid cancer - R. Michael Tuttle | |
| 16.50 - 17.20 | Subclinical hypothyroidism: When to treat? - Spyridoula Maraka | |
| 17.20 - 17.50 | TBC | |
| DAY 3 - Sunday, 23 October 2022 | ||
| MAIN HALL | ||
| 09.00 - 09.30 | Musculoskeletal complications of primary hyperparathyroidism - Claudio Marcocci | |
| 09.30 - 10.00 | Hypercalcemia of malignancy - Ghada El-Hajj Fuleihan | |
| 10.00 - 10.30 | Osteoporosis in young women: Evaluation and therapies - David Kendler | |
| 10.30 - 11.00 | Osteoporosis therapies: combination, sequential and drug interruption - Dolores Shoback | |
| 11.00 - 11.20 | Coffee Break | |
| MAIN HALL | ||
| 11.20 - 11.50 | Functional male hypogonadism - Dimitrios Goulis | |
| 11.50 - 12.20 | Approach to bilateral adrenal masses - Gary Hammer | |
| 12.20 - 12.50 | TBC | |
| 12.50 - 13.20 | TBC | |
| 13.20 - 13.30 | Closing comments and adjourn | |